Although patients with CPT1A deficiency can be identified by NBS, previous studies have shown that milder forms of CPT1A deficiency can be difficult to diagnose because screening markers may be normalized or only slightly increased during follow-up (19, 20). This evidence concerns the gene CPT1A and carnitine palmitoyl transferase 1A deficiency.